AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 57 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $108,000 | -59.1% | 13,130 | -72.2% | 0.00% | -60.0% |
| Q1 2022 | $264,000 | +19.5% | 47,186 | 0.0% | 0.01% | -16.7% |
| Q4 2021 | $221,000 | -49.1% | 47,186 | -32.8% | 0.01% | -25.0% |
| Q3 2021 | $434,000 | +14.5% | 70,180 | +22.1% | 0.01% | +14.3% |
| Q2 2021 | $379,000 | – | 57,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,952,958 | $22,809,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 1,151,175 | $6,642,000 | 0.47% |
| X-Square Capital, LLC | 75,952 | $438,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 68,092 | $393,000 | 0.08% |
| WealthTrust Axiom LLC | 22,347 | $128,000 | 0.05% |
| Opaleye Management Inc. | 58,800 | $339,000 | 0.04% |
| Trexquant Investment LP | 64,838 | $374,000 | 0.04% |
| PDT Partners, LLC | 60,117 | $347,000 | 0.02% |
| PERSONAL CFO SOLUTIONS, LLC | 13,000 | $75,000 | 0.02% |
| CVI Holdings, LLC | 13,171 | $76,000 | 0.01% |